1-3 of 3
Akihiko Shimomura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors

Jun Sato, Toshio Shimizu, Takafumi Koyama, Satoru Iwasa, Akihiko Shimomura, Shunsuke Kondo, Shigehisa Kitano, Kan Yonemori, Yutaka Fujiwara, Kenji Tamura, Takuya Suzuki, Takao Takase, Reiko Nagai, Kohei Yamaguchi, Taro Semba, Zi-Ming Zhao, Min Ren, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1783–1791.
https://doi.org/10.1158/1078-0432.CCR-21-3518
Published: 02 May 2022
View article titled, Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors
Open the PDF for Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori, Takafumi Koyama, Jun Sato, Kenji Tamura, Akihiko Shimomura, Hiroki Ikezawa, Maiko Nomoto, Keiji Furuuchi, Ryo Nakajima, Takuma Miura, Noboru Yamamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 3905–3915.
https://doi.org/10.1158/1078-0432.CCR-20-4740
Published: 15 July 2021
View article titled, First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors
Open the PDF for First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer

Sho Shiino, Juntaro Matsuzaki, Akihiko Shimomura, Junpei Kawauchi, Satoko Takizawa, Hiromi Sakamoto, Yoshiaki Aoki, Masayuki Yoshida, Kenji Tamura, Ken Kato, Takayuki Kinoshita, Yuko Kitagawa, Takahiro Ochiya
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (6): 1817–1827.
https://doi.org/10.1158/1078-0432.CCR-18-1414
Published: 15 March 2019
View article titled, Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer
Open the PDF for Serum miRNA–based Prediction of Axillary Lymph Node Metastasis in Breast Cancer in another window
Includes: Supplementary data